Harel Insurance Investments & Financial Services Ltd. Purchases 15,224 Shares of Doximity, Inc. $DOCS

Harel Insurance Investments & Financial Services Ltd. lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 22.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 83,280 shares of the company’s stock after purchasing an additional 15,224 shares during the quarter. Harel Insurance Investments & Financial Services Ltd.’s holdings in Doximity were worth $6,081,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. GAMMA Investing LLC lifted its stake in shares of Doximity by 5.9% in the second quarter. GAMMA Investing LLC now owns 2,981 shares of the company’s stock valued at $183,000 after buying an additional 165 shares in the last quarter. Louisiana State Employees Retirement System raised its holdings in shares of Doximity by 0.5% in the 2nd quarter. Louisiana State Employees Retirement System now owns 37,600 shares of the company’s stock worth $2,306,000 after acquiring an additional 200 shares during the last quarter. Oregon Public Employees Retirement Fund lifted its position in Doximity by 0.7% in the 3rd quarter. Oregon Public Employees Retirement Fund now owns 27,500 shares of the company’s stock valued at $2,012,000 after acquiring an additional 200 shares in the last quarter. Fairvoy Private Wealth LLC boosted its stake in Doximity by 1.1% during the 3rd quarter. Fairvoy Private Wealth LLC now owns 19,253 shares of the company’s stock valued at $1,408,000 after purchasing an additional 206 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after purchasing an additional 210 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. The Goldman Sachs Group upgraded Doximity from a “neutral” rating to a “buy” rating and set a $49.00 target price on the stock in a report on Friday, January 9th. KeyCorp cut their price objective on shares of Doximity from $75.00 to $60.00 and set an “overweight” rating on the stock in a report on Thursday, January 8th. Barclays assumed coverage on shares of Doximity in a report on Monday, December 8th. They issued an “overweight” rating and a $63.00 target price for the company. Raymond James Financial restated a “strong-buy” rating on shares of Doximity in a report on Monday, December 29th. Finally, Morgan Stanley raised shares of Doximity from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $62.00 to $65.00 in a research report on Monday, December 15th. Two analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Doximity currently has a consensus rating of “Moderate Buy” and a consensus target price of $66.11.

Doximity Stock Performance

Shares of DOCS stock opened at $41.25 on Friday. The firm has a market cap of $7.77 billion, a price-to-earnings ratio of 41.25, a P/E/G ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a 52 week low of $39.95 and a 52 week high of $85.21. The firm’s 50-day simple moving average is $46.35 and its two-hundred day simple moving average is $59.12.

Doximity (NASDAQ:DOCS) last issued its quarterly earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Doximity had a net margin of 36.60% and a return on equity of 21.75%. During the same quarter last year, the company posted $0.30 earnings per share. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. Analysts forecast that Doximity, Inc. will post 0.99 earnings per share for the current year.

Insider Activity at Doximity

In other news, Director Kira Scherer Wampler sold 2,000 shares of the company’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the transaction, the director owned 19,839 shares of the company’s stock, valued at $1,318,103.16. This represents a 9.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 31.30% of the stock is owned by corporate insiders.

About Doximity

Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”

The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.